Andrew Robbins
2023
In 2023, Andrew Robbins earned a total compensation of $7.9M as Chief Executive Officer at Cogent Biosciences, a 80% increase compared to previous year.
Compensation breakdown
| Bonus | $393,659 |
|---|---|
| Option Awards | $4,962,615 |
| Salary | $656,098 |
| Stock Awards | $1,873,200 |
| Other | $13,200 |
| Total | $7,898,772 |
Robbins received $5M in option awards, accounting for 63% of the total pay in 2023.
Robbins also received $393.7K in bonus, $656.1K in salary, $1.9M in stock awards and $13.2K in other compensation.
Rankings
In 2023, Andrew Robbins' compensation ranked 38th out of 3,006 executives tracked by ExecPay. In other words, Robbins earned more than 98.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 38 out of 3,006 | 99th |
Division Manufacturing | 17 out of 1,650 | 99th |
Major group Chemicals And Allied Products | 12 out of 918 | 99th |
Industry group Drugs | 11 out of 881 | 99th |
Industry Pharmaceutical Preparations | 6 out of 637 | 99th |
Source: SEC filing on April 23, 2024.
Robbins' colleagues
We found two more compensation records of executives who worked with Andrew Robbins at Cogent Biosciences in 2023.